EPO and chronic kidney disease: Whereas patients with CKD receiving EPO can have low serum iron requiring supplementation, it is possible herein that the elevated serum iron we observed in the CKD‐EPO group was potentially due to inhibiting further erythropoiesis and limiting iron utilization since a polycythemic state was reached.